These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33120702)

  • 1. Idiopathic thrombocytopenic purpura and its fundus features in a patient with diabetes mellitus.
    Rajesh R; Shanmugam MP; Sagar P
    Indian J Ophthalmol; 2020 Nov; 68(11):2587-2589. PubMed ID: 33120702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystoid macular edema related to diabetic retinopathy with retinitis pigmentosa.
    Hotta K; Hotta J
    Jpn J Ophthalmol; 2006; 50(4):390-393. PubMed ID: 16897230
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.
    Lee YJ; Kim M
    Korean J Ophthalmol; 2019 Apr; 33(2):198-199. PubMed ID: 30977331
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Cysts in Red and Green Images for Diabetic Macular Edema.
    Alhamami MA; Elsner AE; Malinovsky VE; Clark CA; Haggerty BP; Ozawa GY; Cuadros JA; Baskaran K; Gast TJ; Litvin TV; Muller MS; Brahm SG; Young SB; Miura M
    Optom Vis Sci; 2017 Feb; 94(2):137-149. PubMed ID: 27846063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pars plana vitrectomy in diabetic macular edema.
    Micelli Ferrari T; Cardascia N; Durante G; Vetrugno M; Cardia L
    Doc Ophthalmol; 1999; 97(3-4):471-4. PubMed ID: 10896366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
    Blindbæk SL; Peto T; Grauslund J
    Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic macular oedema: what to fear? How to treat?
    Grauslund J; Blindbaek SL
    Acta Ophthalmol; 2017 Mar; 95(2):117-118. PubMed ID: 28205409
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic macular edema: Evidence-based management.
    Browning DJ; Stewart MW; Lee C
    Indian J Ophthalmol; 2018 Dec; 66(12):1736-1750. PubMed ID: 30451174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive subretinal and vitreous haemorrhages at presentation in idiopathic thrombocytopenic purpura: report of a case and review of literature.
    Goel N; Arora S; Jain P; Ghosh B
    Clin Exp Optom; 2014 May; 97(3):270-3. PubMed ID: 23763572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Diabetic Macular Edema.
    Moisseiev E; Loewenstein A
    Ophthalmic Res; 2017; 58(1):15-17. PubMed ID: 28288460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema.
    Ratra D
    Indian J Ophthalmol; 2021 Feb; 69(2):367-368. PubMed ID: 33463594
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography.
    Pemp B; Deák G; Prager S; Mitsch C; Lammer J; Schmidinger G; Scholda C; Schmidt-Erfurth U; Bolz M;
    Retina; 2014 Dec; 34(12):2407-15. PubMed ID: 25062440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome in diabetic macular edema.
    Saxena S
    Indian J Ophthalmol; 1997 Dec; 45(4):260-1. PubMed ID: 9567027
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.
    Bahrami B; Hong T; Schlub TE; Chang AA
    Retina; 2019 Jan; 39(1):61-68. PubMed ID: 30015767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
    Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.